Mkts

Voyager Therapeutics, Inc.

NASDAQ: VYGR
$1.63-0.10 (-5.78%)
As of Nov 16, 4:00 PM ET

Key statistics

Day range
1.621.74
52-week range
1.585.48
Today
Open1.70
Previous close1.63
Volume1.19M
Valuation
Market cap103.52M
P/E ratio—
EPS (TTM)-1.81
Income & risk
Dividend / yield—
Beta1.21
Avg volume706.6K
Discussion

VYGR News

Stories mentioning VYGR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,59315,33613,3655,2006,4736,27824,62929,578
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development24,60235,95235,86631,33031,52635,58330,24134,452
Sales General & Admin
Total Operating Expenses32,86345,26843,95941,82541,16644,57738,40944,603
Operating Income (Loss)(30,270)(29,932)(30,594)(36,625)(34,693)(38,299)(13,780)(15,025)
Interest Income
Interest Expense
Other Expense435.00404.00400.00427.00418.00200.0020.00
Pretax Income(27,923)(27,417)(27,809)(33,367)(30,984)(33,903)(9,001)(10,117)
Tax Provision14.009.0083.0015.0037.00584.0043.0024.00
Net Income (Loss)(27,937)(27,426)(27,892)(33,382)(31,021)(34,487)(9,044)(10,141)
Earnings Per Share (Basic)(0.47)(0.47)(0.47)(0.57)(0.53)(0.60)(0.16)(0.18)
Earnings Per Share (Diluted)(0.47)(0.47)(0.47)(0.57)(0.53)(0.60)(0.16)(0.18)
Weighted Average Shares Outstanding (Basic)59,49658,69158,80358,66658,35057,66857,85157,722
Weighted Average Shares Outstanding (Diluted)59,49658,69158,80358,66658,35057,66857,85157,722

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VYGR

Voyager Therapeutics, Inc. (NASDAQ: VYGR) is a stock listed on the Nasdaq Stock Market under the ticker symbol VYGR. It last traded at $1.63 (Nov 16, 2026, 4:00 PM ET), down 5.8% on the day. That gives Voyager Therapeutics a market capitalisation of $103.5M.

Over the past 52 weeks VYGR has traded between $1.58 and $5.48.

Revenue for the quarter ended Mar 31, 2026 was $2.6M; a net loss of $27.9M. Revenue was down 59.9% from $6.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$2.6M-$27.9M-1077.4%
Dec 31, 2025$15.3M-$27.4M-178.8%
Sep 30, 2025$13.4M-$27.9M-208.7%
Jun 30, 2025$5.2M-$33.4M-642.0%

From Voyager Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…